The Parkinson’s Foundation and the U.S. Department of Veterans Affairs (VA), Ralph H. Johnson VA Medical Center in South Carolina are hosting a virtual symposium next month for all veterans […]
Bayer, the maker of Roundup weed killer, has agreed to increase the compensation the company will pay to resolve future non-Hodgkin’s lymphoma claims to $2 billion, after announcing an initial
Bayer Increases Payout for Future Roundup Cancer Claims to $2 Billion Read More »
Bayer, the maker of the female sterilization device Essure, announced last week that it would pay about $1.6 billion to resolve approximately 90% of the nearly 39,000 U.S. Essure claims
Bayer Agrees to Settle Essure Injury Lawsuits for $1.6 Billion Read More »
Bayer, the maker of the highly controversial Roundup weed killer, has announced a plan to settle most of the Roundup cancer lawsuits currently pending against the company, as well as
Bayer Will Pay $10 Billion to Resolve Tens of Thousands of Roundup Cancer Claims Read More »
Learn More About Elmiron Learn more about Elmiron Vision Loss risks and lawsuits by clicking on the link here: Elmiron Vision Loss Dismiss this alert. Significant new safety warnings have
Major Elmiron Warning Label Update Highlights Risk of Retinal Damage Side Effects Read More »
The surviving family member of a Pennsylvania man who died from pancreatic cancer last year has filed a wrongful death lawsuit against the makers of Zantac, alleging that years of
Family Sues Zantac Makers Over Fatal Case of Pancreatic Cancer Read More »
Faced with nearly 20,000 lawsuits involving talcum powder cancer claims, Johnson & Johnson announced this week that it will no longer sell talc-based Baby Powder, a product that has been
J&J Discontinues Talc-Based Baby Powder Amid Nearly 20,000 Cancer Claims Read More »
The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn
A California appeals court has reinstated the eligibility of thousands of cases against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary, alleging that the company’s antipsychotic drug Risperdal causes abnormal
Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson Read More »
A recent ruling from a federal judge in New Jersey has cleared the way for thousands of talcum powder cancer lawsuits against Johnson & Johnson to proceed. The ruling, handed
Daubert Ruling Green Lights 16,000 Talcum Powder Cases Against Johnson & Johnson Read More »
